[go: up one dir, main page]

ECSP11011464A - Tia-triaza-ciclopentazulenos - Google Patents

Tia-triaza-ciclopentazulenos

Info

Publication number
ECSP11011464A
ECSP11011464A EC2011011464A ECSP11011464A ECSP11011464A EC SP11011464 A ECSP11011464 A EC SP11011464A EC 2011011464 A EC2011011464 A EC 2011011464A EC SP11011464 A ECSP11011464 A EC SP11011464A EC SP11011464 A ECSP11011464 A EC SP11011464A
Authority
EC
Ecuador
Prior art keywords
ciclopentazulenos
triaza
tia
medicine
excessive
Prior art date
Application number
EC2011011464A
Other languages
English (en)
Inventor
Tobias Wunberg
Der Veen Lars Anders Van
Darryl Mcconnell
Siegfried Schneider
Original Assignee
Boehringer Ingelheim Internat Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Internat Gmbh filed Critical Boehringer Ingelheim Internat Gmbh
Publication of ECSP11011464A publication Critical patent/ECSP11011464A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • Communicable Diseases (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

La presente invención comprende compuestos de fórmula general (1)en la que de R1 a R3 y X se definen como en la reivindicación 1, que son adecuados para el tratamiento de enfermedades caracterizadas por una proliferación celular excesiva o anormal, y el uso de los mismos para preparar un medicamento que tenga las propiedades mencionadas anteriormente.
EC2011011464A 2009-04-22 2011-11-17 Tia-triaza-ciclopentazulenos ECSP11011464A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP09158493 2009-04-22

Publications (1)

Publication Number Publication Date
ECSP11011464A true ECSP11011464A (es) 2011-12-30

Family

ID=40996623

Family Applications (1)

Application Number Title Priority Date Filing Date
EC2011011464A ECSP11011464A (es) 2009-04-22 2011-11-17 Tia-triaza-ciclopentazulenos

Country Status (21)

Country Link
US (1) US8288379B2 (es)
EP (1) EP2421871B1 (es)
JP (1) JP5658231B2 (es)
KR (1) KR20120014152A (es)
CN (1) CN102459282A (es)
AP (1) AP2011005893A0 (es)
AR (1) AR076364A1 (es)
AU (1) AU2010240965A1 (es)
BR (1) BRPI1016174A2 (es)
CA (1) CA2759595A1 (es)
CO (1) CO6460760A2 (es)
EA (1) EA201101537A1 (es)
EC (1) ECSP11011464A (es)
IL (1) IL215199A0 (es)
MA (1) MA33223B1 (es)
MX (1) MX2011011065A (es)
SG (1) SG175746A1 (es)
TN (1) TN2011000530A1 (es)
TW (1) TW201103942A (es)
UY (1) UY32566A (es)
WO (1) WO2010122071A1 (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20160091060A (ko) 2015-01-23 2016-08-02 전관식 약제 분배장치 및 분말약 분배방법
ITRM20150212A1 (it) * 2015-05-15 2016-11-15 Univ Degli Studi Di Palermo 4,5,6,9-tetraidropirrolo[2',3':3,4] cicloepta[1,2-d] isossazoli, procedimento per la loro produzione e loro uso come antitumorali

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9024A (en) * 1852-06-15 Motion of the lay in looms
US5547975A (en) * 1994-09-20 1996-08-20 Talley; John J. Benzopyranopyrazolyl derivatives for the treatment of inflammation
RU2403258C2 (ru) * 2004-10-07 2010-11-10 Бёрингер Ингельхайм Интернациональ Гмбх Тиазолилдигидроиндазолы
UY29149A1 (es) 2004-10-07 2006-05-31 Boehringer Ingelheim Int Tiazolil-dihidro-indazoles
US8779154B2 (en) * 2006-09-26 2014-07-15 Qinglin Che Fused ring compounds for inflammation and immune-related uses
JP5901020B2 (ja) * 2009-04-22 2016-04-06 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング 癌の治療用ＰＩ３−キナーゼ阻害薬としてのチア−トリアザ−ａｓ−インダセン

Also Published As

Publication number Publication date
JP5658231B2 (ja) 2015-01-21
EP2421871B1 (en) 2015-09-16
MX2011011065A (es) 2011-11-04
CA2759595A1 (en) 2010-10-28
US20110112087A1 (en) 2011-05-12
UY32566A (es) 2010-11-30
MA33223B1 (fr) 2012-04-02
EA201101537A1 (ru) 2012-05-30
AP2011005893A0 (en) 2011-10-31
TW201103942A (en) 2011-02-01
CN102459282A (zh) 2012-05-16
US8288379B2 (en) 2012-10-16
CO6460760A2 (es) 2012-06-15
KR20120014152A (ko) 2012-02-16
BRPI1016174A2 (pt) 2016-04-19
EP2421871A1 (en) 2012-02-29
AU2010240965A1 (en) 2011-10-20
JP2012524751A (ja) 2012-10-18
TN2011000530A1 (en) 2013-05-24
AR076364A1 (es) 2011-06-08
SG175746A1 (en) 2011-12-29
IL215199A0 (en) 2011-12-29
WO2010122071A1 (en) 2010-10-28

Similar Documents

Publication Publication Date Title
UY33199A (es) 5-alquinil-pirimidinas.
ECSP099823A (es) Nuevos compuestos químicos
ECSP12011830A (es) Nuevos compuestos.
ECSP11011079A (es) Nuevos compuestos de hidroxiareno.
UY32009A (es) 5-alquinil-pirimidinas
ECSP088932A (es) Nuevos compuestos químicos
ECSP11010816A (es) Nuevos Compuestos
ECSP13012448A (es) Nuevas aminopirazoloquinazolinas.
ECSP078060A (es) 2,4-diamino-pirimidinas como inhibidores de aurora
UY33890A (es) Nuevas azaindolilfenil sulfonamidas como inhibidores de serina/ treonina cinasa
UY32494A (es) Nuevas 2,4-diaminopirimidinas, sales farmacéuticas de las mismas, composiciones conteniéndolas y aplicaciones
UY32240A (es) Nuevas 2,4-diaminopirimidinas, sus sales farmacéuticamente aceptables, composiciones conteniéndolas y aplicaciones.
UY33817A (es) ?nuevas oxindolpirimidinas bencílicas?.
UY31982A (es) Derivados de 1,2-dihidropiridin-3-carboxamidas n-sustituidas
DOP2015000157A (es) Lactamas fusionadas de arilo y heteroarilo
ECSP088905A (es) Nuevos compuestos
PE20151023A1 (es) Triazolopirazinas
ECSP11010930A (es) Nuevos compuestos químicos
ECSP11011558A (es) Nuevos compuestos químicos.
UY31138A1 (es) Derivados de indolinonas sustituidas, composiciones conteniendolos y aplicaciones
UY33176A (es) Derivados de oxazolopirimidina sustituida en 2, 5, 7.
CO6290768A2 (es) Tiazolil-dihidro-indazoles
CO6460762A2 (es) 5-alquinil-piridinas
UY33181A (es) Derivados de oxazolopirimidina 2,5-sustituidos.
ECSP11011464A (es) Tia-triaza-ciclopentazulenos